Literature DB >> 32481502

Use of Non-Pharmacological Supplementations in Children and Adolescents with Attention Deficit/Hyperactivity Disorder: A Critical Review.

Eleonora Rosi1, Silvia Grazioli1, Filippo Maria Villa1, Maddalena Mauri1,2, Erica Gazzola3, Marco Pozzi4, Massimo Molteni1, Maria Nobile1.   

Abstract

Attention deficit hyperactivity disorder (ADHD) is a common neurodevelopmental disorder in children and adolescents, with environmental and biological causal influences. Pharmacological medication is the first choice in ADHD treatment; recently, many studies have concentrated on dietary supplementation approaches to address nutritional deficiencies, to which part of non-responses to medications have been imputed. This review aims to evaluate the efficacy of non-pharmacological supplementations in children or adolescents with ADHD. We reviewed 42 randomized controlled trials comprised of the following supplementation categories: polyunsaturated fatty acids (PUFAs), peptides and amino acids derivatives, single micronutrients, micronutrients mix, plant extracts and herbal supplementations, and probiotics. The reviewed studies applied heterogeneous methodologies, thus making it arduous to depict a systematic overview. No clear effect on single cognitive, affective, or behavioral domain was found for any supplementation category. Studies on PUFAs and micronutrients found symptomatology improvements. Peptides and amino acids derivatives, plant extracts, herbal supplementation, and probiotics represent innovative research fields and preliminary results may be promising. In conclusion, such findings, if confirmed through future research, should represent evidence for the efficacy of dietary supplementation as a support to standard pharmacological and psychological therapies in children and adolescents with ADHD.

Entities:  

Keywords:  adolescents; attention deficit hyperactivity disorder (ADHD); children; dietary supplementations; neurodevelopment; non-pharmacological treatment; rehabilitation

Mesh:

Substances:

Year:  2020        PMID: 32481502      PMCID: PMC7352506          DOI: 10.3390/nu12061573

Source DB:  PubMed          Journal:  Nutrients        ISSN: 2072-6643            Impact factor:   5.717


  70 in total

1.  l-Carnosine as Adjunctive Therapy in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Authors:  Alireza Ghajar; Farinaz Aghajan-Nashtaei; Mohsen Afarideh; Mohammad-Reza Mohammadi; Shahin Akhondzadeh
Journal:  J Child Adolesc Psychopharmacol       Date:  2018-02-22       Impact factor: 2.576

2.  The effect of phosphatidylserine containing Omega3 fatty-acids on attention-deficit hyperactivity disorder symptoms in children: a double-blind placebo-controlled trial, followed by an open-label extension.

Authors:  I Manor; A Magen; D Keidar; S Rosen; H Tasker; T Cohen; Y Richter; D Zaaroor-Regev; Y Manor; A Weizman
Journal:  Eur Psychiatry       Date:  2011-07-31       Impact factor: 5.361

3.  Ningdong granule: a complementary and alternative therapy in the treatment of attention deficit/hyperactivity disorder.

Authors:  Ji-Jun Li; Zai-Wang Li; Shu-Zhen Wang; Fang-Hua Qi; Lin Zhao; Hong Lv; An-Yuan Li
Journal:  Psychopharmacology (Berl)       Date:  2011-03-18       Impact factor: 4.530

Review 4.  Catecholamine influences on prefrontal cortical function: relevance to treatment of attention deficit/hyperactivity disorder and related disorders.

Authors:  Amy F T Arnsten; Steven R Pliszka
Journal:  Pharmacol Biochem Behav       Date:  2011-02-02       Impact factor: 3.533

5.  Consumption of fermented milk product with probiotic modulates brain activity.

Authors:  Kirsten Tillisch; Jennifer Labus; Lisa Kilpatrick; Zhiguo Jiang; Jean Stains; Bahar Ebrat; Denis Guyonnet; Sophie Legrain-Raspaud; Beatrice Trotin; Bruce Naliboff; Emeran A Mayer
Journal:  Gastroenterology       Date:  2013-03-06       Impact factor: 22.682

6.  Ginkgo biloba for attention-deficit/hyperactivity disorder in children and adolescents: a double blind, randomized controlled trial.

Authors:  Bahman Salehi; Reza Imani; Mohammad Reza Mohammadi; Jalil Fallah; Mohammad Mohammadi; Ahmad Ghanizadeh; Ali Akbar Tasviechi; Ardalan Vossoughi; Shams-Ali Rezazadeh; Shahin Akhondzadeh
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2009-10-05       Impact factor: 5.067

7.  Vitamin-mineral treatment improves aggression and emotional regulation in children with ADHD: a fully blinded, randomized, placebo-controlled trial.

Authors:  Julia J Rucklidge; Matthew J F Eggleston; Jeanette M Johnstone; Kathryn Darling; Chris M Frampton
Journal:  J Child Psychol Psychiatry       Date:  2017-10-02       Impact factor: 8.982

8.  Supplementation with high-content docosahexaenoic acid triglyceride in attention-deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial.

Authors:  Celestino Rodríguez; Trinidad García; Débora Areces; Estrella Fernández; Marcelino García-Noriega; Joan Carles Domingo
Journal:  Neuropsychiatr Dis Treat       Date:  2019-05-08       Impact factor: 2.570

9.  Effect of omega-3 plus methylphenidate as an alternative therapy to reduce attention deficit-hyperactivity disorder in children.

Authors:  Soleiman Mohammadzadeh; Narmin Baghi; Fayegh Yousefi; Bahar Yousefzamani
Journal:  Korean J Pediatr       Date:  2019-05-20

10.  Does omega-3 supplement enhance the therapeutic results of methylphenidate in attention deficit hyperactivity disorder patients?

Authors:  Fatemeh Behdani; Paria Hebrani; Afshin Naseraee; Mehri Baghban Haghighi; Amir Akhavanrezayat
Journal:  J Res Med Sci       Date:  2013-08       Impact factor: 1.852

View more
  2 in total

1.  Composition of the Gut Microbiota in Attention Deficit Hyperactivity Disorder: A Systematic Review and Meta-Analysis.

Authors:  Ning Wang; Xuping Gao; Zifeng Zhang; Li Yang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-18       Impact factor: 5.555

Review 2.  ADHD: Reviewing the Causes and Evaluating Solutions.

Authors:  Luis Núñez-Jaramillo; Andrea Herrera-Solís; Wendy Verónica Herrera-Morales
Journal:  J Pers Med       Date:  2021-03-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.